DaVita Inc. vs Johnson & Johnson
DVA vs JNJ — side-by-side comparison from reported financials. DVA leads 5, JNJ leads 5 of 10 comparable metrics.
DaVita Inc.
DVA · Healthcare
$179.25+1.26%Strained
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | DVA | JNJ |
|---|---|---|
| Price | $179.25 | $261.79 |
| Market cap | $11.4B | $631B |
| Revenue (TTM) | $14.0B | $97.9B |
| Revenue growth | +5.5% | +5.6% |
| Net margin | 6.0% | 21.5% |
| Free cash flow | $1.61B | $22.2B |
| Net cash (debt) | ($9.57B) | ($27.8B) |
| 1-year price return | +41.8% | +37.0% |
| P/E | 13.5 | 29.9 |
| P/E vs own history (cheap-side %) | 54% | 16% |
| Dividend yield | — | 2.00% |
| Return on equity | 181% | 26% |
| CV checks passed | 8 of 10 | 10 of 10 |
| Employees | 78,000 | 140,800 |
Full résumé-style profiles: DVA CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.